# Feasibility of interoperability to drive the Hepatitis C Treatment Market Author: Pal Sinha, Barnali Author URL: https://financedigest.com/author/pal-sinha-barnali Published: 2021-11-29 Category: Research Reports Category URL: https://financedigest.com/category/research-reports Meta Title: Revolutionising Hepatitis C Treatment Market: Future Trends Meta Description: Discover how connectivity and technology advancements are shaping the future of healthcare, with a focus on the Hepatitis C Treatment Market. Find key insights URL: https://financedigest.com/feasibility-of-interoperability-to-drive-the-hepatitis-c-treatment-markethtml ![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836822317-compressed.jpg) The Hepatitis C Treatment Market is slated to witness exponentiation going forward. The IoMT (Internet-of-Medical-Things) is already [transforming every walk](https://www.financedigest.com/the-d-mannose-market-to-walk-through-digital-transformation-stampede.html "The D-Mannose Market To Walk Through Digital Transformation Stampede") of life, including healthcare. Healthcare IT has let both – patients and doctors carry/download information about each other anywhere and anytime through their smartphones/tabs. In other words, more [connectivity translates to better access to data](https://www.financedigest.com/smartcontract-com-used-by-swift-announces-technical-leaders-as-advisors-launches-chainlink-to-connect-smart-contracts-to-off-chain-data-payments.html "SmartContract.com, Used by SWIFT, Announces Technical Leaders as Advisors, Launches ChainLink to Connect Smart Contracts to Off-chain Data & Payments"), thereby rendering better healthcare for patients. This would be the [future of the healthcare](https://www.financedigest.com/the-future-of-healthcare.html "The future of healthcare") vertical in the upcoming period. The [**Hepatitis C Treatment Market**](https://www.persistencemarketresearch.com/market-research/hepatitis-c-treatment-market.asp) will be worth **US$ 71.13 Billion** at a **CAGR of 13.1%** from **2024**. With interconnected ecosystems taking the [center stage](https://www.financedigest.com/2021-predictions-operational-resilience-takes-center-stage.html "2021 Predictions: Operational Resilience Takes Center Stage"), advancements in technology are bound to bring about a digital alteration in the healthcare vertical. Also, bio-based medications are on the anvil. Persistence **[Market Research (PMR) delivers key insights on the global hepatitis C treatment market in its latest report titled “Hepatitis C Treatment Market:](https://www.financedigest.com/constructive-digitization-to-drive-the-non-infectious-macular-edema-treatment-market.html "Constructive Digitization to drive the Non Infectious Macular Edema Treatment Market") Global Industry Analysis and Forecast, 2016–2024”.** The global hepatitis C treatment market was **valued at US$ 23.9 Bn in 2015** and is estimated to be valued at **US$ 26.6 Bn by 2016**. The **[market is expected to reach a valuation](https://www.financedigest.com/ott-content-market-to-rise-to-a-valuation-of-us-245814-4-mn.html "OTT Content Market to rise to a valuation of US$ 245,814.4 Mn") of US$ 71.13 Bn** by the end of 2024, reflecting a **CAGR of 13.1%** over the forecast period. **Market dynamics** [Growth of the global hepatitis C treatment market](https://www.financedigest.com/the-uveitis-treatment-market-to-join-the-growth-adsorption-spectrum.html "The Uveitis Treatment Market to join the growth adsorption spectrum") is primarily driven by factors such as increase in the prevalence of hepatitis C infections in the U.S. and Canada and rising per capita healthcare expenditure [across the globe](https://www.financedigest.com/sales-of-medical-beds-across-the-globe-are-estimated-to-exceed-us-3000-mn-in-revenues-by-2022-end.html "Sales of Medical Beds Across the Globe are Estimated to Exceed US$ 3,000 Mn in Revenues by 2022-end"). Also [government initiatives to control infection](https://www.financedigest.com/watchdog-warned-uk-government-of-spyware-infections-inside-10-downing-street.html "Watchdog warned UK government of spyware infections inside 10 Downing Street") and various private NGOs creating awareness about treatment is also fueling the market growth. **Get Going With Sample Of Hepatitis C Treatment Market Report!** **https://www.persistencemarketresearch.co/samples/3602** **Company Profiles** - Gilead Sciences, Inc. - AbbVie Inc. - Kadmon Holdings, Inc. - F. Hoffmann-La Roche Ltd - GlaxoSmithKline plc. - Bristol-Myers Squibb Company - Merck & Co., Inc. - Johnson & Johnson **Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:msales@persistencemarketresearch.com) However, high cost associated with hepatitis C treatment drugs and lack of awareness about hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and Latin America is [expected to impede growth of the global hepatitis C treatment market](https://www.financedigest.com/provoked-vestibulodynia-treatment-market-expectations-and-growth-trends-highlighted-until-2028.html "Provoked Vestibulodynia Treatment Market Expectations and Growth Trends Highlighted Until 2028"). [**Market forecast**](https://www.financedigest.com/hard-disc-drive-market-current-and-future-demand-analysis-growth-and-forecast-by-2029.html "Hard Disc Drive Market Current and Future Demand, Analysis, Growth and Forecast By 2029") By drug class, the [market is segmented into HCV Protease Inhibitors](https://www.financedigest.com/innovation-to-augment-the-immune-checkpoint-inhibitors-market.html "Innovation to augment the Immune Checkpoint Inhibitors Market"), HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral which is again sub-divided into various drugs sub segments. The combination segment is expected to contribute a maximum share to the global hepatitis C treatment **[market and register the fastest CAGR](https://www.financedigest.com/augmented-reality-and-virtual-reality-market-to-register-a-cagr-of-42-2.html "Augmented Reality and Virtual Reality Market to register a CAGR of 42.2% ") of 13.9%** during the forecast period. By distribution channel, the [market is segmented into Hospital](https://www.financedigest.com/cyclic-innovation-to-drive-the-hospital-acquired-infection-control-market.html "Cyclic innovation to drive the Hospital Acquired Infection Control Market") Pharmacies, Retail Pharmacies and Online Pharmacies. Among these, the hospital pharmacies segment is anticipated to be dominant throughout the forecast period and is projected to account for about 43.7% share of the total global hepatitis C [treatment market](https://www.financedigest.com/the-the-irritable-bowel-syndrome-treatment-market-to-subvert-monotony.html "The The Irritable Bowel Syndrome Treatment Market to subvert monotony") revenue by 2024. The hospital pharmacies segment is anticipated to emerge as the most attractive segment in the global hepatitis C treatment [market owing to growing instances of hospitalization and improved accessibility](https://www.financedigest.com/fico-and-efl-partner-to-extend-access-to-credit-for-unscoreable-consumers-and-entrepreneurs-in-multiple-markets.html "FICO and EFL Partner to Extend Access to Credit for “Unscoreable” Consumers and Entrepreneurs in Multiple Markets") and services. The online pharmacies segment is expected to [register the fastest CAGR](https://www.financedigest.com/photonic-sensors-detectors-market-to-register-a-cagr-of-7-2.html "Photonic Sensors & Detectors Market to register a CAGR of 7.2%") during the forecast period and is estimated to create absolute $ opportunity of **US$ 713.8 Mn** in 2017 over 2016. **Keeping A Tab On Key Players In The Hepatitis C Treatment Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Hepatitis C Treatment Market Report!** [**https://www.persistencemarketresearch.com/checkout/3602**](https://www.persistencemarketresearch.com/checkout/3602) The online pharmacies segment is expected to [witness significant growth](https://www.financedigest.com/bowel-stimulators-market-is-set-to-witness-a-6-3-growth-during-the-year-2021-2031.html "Bowel Stimulators Market is set to witness a 6.3% growth during the year 2021-2031") during the forecast period and this can be attributed to high availability of hepatitis C treatment drugs and discounts provided by online pharmacies. This report covers global and regional trends along with an [analysis of the market](https://www.financedigest.com/aspartic-acid-market-outlook-current-and-future-industry-landscape-analysis-2029.html "Aspartic Acid Market Outlook, Current and Future Industry Landscape Analysis 2029") potential. North America is estimated to account for 45% share in the global hepatitis C [treatment market](https://www.financedigest.com/the-dry-eye-syndrome-treatment-market-to-have-growth-devised-on-innovation.html "The Dry Eye Syndrome Treatment Market to have growth devised on innovation") by 2016, whereas Asia Pacific is projected to grow at a healthy **CAGR of 14.8%** due to increasing awareness about hepatitis C infections. Europe region is expected to account for 19.6% share in the global hepatitis C [treatment market](https://www.financedigest.com/customized-innovation-to-drive-the-alopecia-treatment-market.html "Customized innovation to drive the Alopecia Treatment Market") by 2016 end. Latin America was valued at **US$ 2,915.8 Mn in 2015** and is estimated to reach **US$ 3,311.1 Mn by 2016**, with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa region was [valued at US$ 1,792.5 Mn in 2015 and is estimated to reach](https://www.financedigest.com/security-and-vulnerability-management-market-was-valued-at-us-5749-5-mn-in-2016-and-is-projected-to-reach-us-20665-9-mn-by-2027.html "Security and Vulnerability Management Market was valued at US$ 5,749.5 Mn in 2016 and is projected to reach US$ 20,665.9 Mn by 2027") US$ 1,988.1 Mn by 2016. **About us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp) **Contact us:** **[Persistence Market](https://www.financedigest.com/persistence-innovation-to-replenish-the-novel-sweeteners-market.html "Persistence Innovation To Replenish The Novel Sweeteners Market") Research** Address – 305 Broadway, 7th Floor, New [York City](https://www.financedigest.com/dr-letao-qin-joins-rimon-as-partner-in-its-research-triangle-park-and-new-york-city-offices.html "Dr.Letao Qin, joins Rimon as Partner in its Research Triangle Park and New York City Offices"), NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 **Sales** – sales@persistencemarketresearch.com b --- This blog is powered by Superblog. Visit https://superblog.ai to know more. ---